Data provided by iNet BFA
Loading...
See More

Aspen finalises GSK deal for £164m

Dec 03 2012 08:22 Reuters

Shutterstock

Company Data

ASPEN PHARMACARE HOLDINGS LIMITED [JSE:APN]

Last traded 316.00
Change 5.64
% Change 0.02
Cumulative volume 564944
Market cap 144.20bn

Last Updated: 02/09/2014 at 04:25. Prices are delayed by 15 minutes. Source: McGregor BFA

Related Articles

Aspen boosts profit, Asian unit robust

Aspen buys GSK Aussie drugs for R2.2bn

Aspen unit to buy drug portfolio from GSK

Aspen prepared to help bridge ARV shortages

Aspen buys GSK brands

Aspen: Earning to between rise 18%-24%

 

Johannesburg - Aspen Pharmacare Holdings [JSE:APN] said on Monday it has finalised the acquisition of medicines from GlaxoSmithKline for £163.8m.

The deal, announced in August, was initially pegged at £172m.

 
NEXT ON FIN24X

 
 
 

Read Fin24’s Comments Policy

24.com publishes all comments posted on articles provided that they adhere to our Comments Policy. Should you wish to report a comment for editorial review, please do so by clicking the 'Report Comment' button to the right of each comment.

Comment on this story
0 comments
Add your comment
Comment 0 characters remaining
 

Company Snapshot

We're talking about:

Small Business

“Hippie sense makes business sense,” an entrepreneur said, adding that "purpose" was core to success.
 

Money Clinic

Money Clinic
Do you have a question about your finances? We'll get an expert opinion.
Click here...
Loading...